| Literature DB >> 33329448 |
Md Mahi Imam Mollah1, Miltan Chandra Roy1, Doo-Yeol Choi1, Md Ariful Hasan1, Md Abdullah Al Baki1, Hyun-Suk Yeom2, Yonggyun Kim1.
Abstract
Xenorhabdus hominickii ANU1 is known to be an entomopathogenic bacterium symbiotic to nematode Steinernema monticolum. Another bacterial strain X. hominickii DY1 was isolated from a local population of S. monticolum. This bacterial strain X. hominickii DY1 was found to exhibit high insecticidal activities against lepidopteran and coleopteran species after hemocoelic injection. However, these two X. hominickii strains exhibited significant variations in insecticidal activities, with ANU1 strain being more potent than DY1 strain. To clarify their virulence difference, bacterial culture broths of these two strains were compared for secondary metabolite compositions. GC-MS analysis revealed that these two strains had different compositions, including pyrrolopyrazines, piperazines, cyclopeptides, and indoles. Some of these compounds exhibited inhibitory activities against phospholipase A2 to block eicosanoid biosynthesis and induce significant immunosuppression. They also exhibited significant insecticidal activities after oral feeding, with indole derivatives being the most potent. More kinds of indole derivatives were detected in the culture broth of ANU1 strain. To investigate variations in regulation of secondary metabolite production, expression level of leucine-responsive regulatory protein (Lrp), a global transcription factor, was compared. ANU1 strain exhibited significantly lower Lrp expression level than DY1 strain. To assess genetic variations associated with secondary metabolite synthesis, bacterial loci encoding non-ribosomal protein synthase and polyketide synthase (NRPS-PKS) were compared. Three NRPS and four PKS loci were predicted from the genome of X. hominickii. The two bacterial strains exhibited genetic variations (0.12∼0.67%) in amino acid sequences of these NRPS-PKS. Most NRPS-PKS genes exhibited high expression peaks at stationary phase of bacterial growth. However, their expression levels were significantly different between the two strains. These results suggest that differential virulence of the two bacterial strains is caused by the difference in Lrp expression level, leading to difference in the production of indole compounds and other NRPS-PKS-associated secondary metabolites.Entities:
Keywords: Lrp; NRPS; PKS; Xenorhabdus hominickii; eicosanoids; secondary metabolite
Year: 2020 PMID: 33329448 PMCID: PMC7732475 DOI: 10.3389/fmicb.2020.583594
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
FIGURE 1An entomopathogenic nematode (EPN) isolate multiplied in S. exigua host. (A) Symptom of a dead insect larva infected (+) with the nematode isolate compared to an uninfected (−) healthy larva. (B) Release of infective juveniles (IJs) from the dead larva. (C) Morphological characters of IJs, including total body length from a whole view, lateral view showing excretory pore (‘Ep’), and terminal view showing tail. IJs were topically applied onto L5 larvae of S. exigua. IJs were fixed in triethanolamine formalin for observation under a phase contrast microscope.
FIGURE 2Molecular identification of an EPN isolate using ITS sequence (GenBank accession number: AF122017.1). (A) Two ITS sequences (‘ITS-1’ and ‘ITS-2’) between neighboring ribosomal RNA (rRNA) sequences. These two ITS regions are marked with boxes. (B) Phylogeny analysis of EPN isolate with other EPNs. The tree was constructed with the Neighbor-joining method using MEGA6. Bootstrapping values on branches were obtained with 1,000 repetitions. GenBank accession numbers of ITS/rRNA sequences follow their own species names.
FIGURE 3A bacterial isolate from S. monticolum. (A) Blue colonies on NBTA plate medium. (B) TEM photo of the bacterium showing flagella. Scale bar, 2 μm. (C) Symptom of a dead larva infected with the bacterial isolate. From NBTA plate, single blue colonies were sub-cultured into TSB media. Overnight grown bacteria were injected into L5 larvae of S. exigua for pathogenicity analysis.
FIGURE 4Virulence of X. hominickii DY1 against different insects of two lepidopteran species (S. exigua and P. xylostella at L5 larval stage) and one coleopteran species (T. molitor at larval stage with 3-cm body length). (A) Dose-mortality curve at 24 h after bacterial infection. Overnight cultured bacteria were injected into hemocoels of surface-sterilized larvae using microsyringes. (B) Medium lethal dose (LD50). LD50 values are expressed as colony forming unit (cfu) of bacteria per larva. Each treatment was replicated three times. Each replication used 10 larvae.
FIGURE 5Differential virulence of two X. hominickii strains (‘ANU1’ and ‘DY1’) against two lepidopteran species (S. exigua and M. vitrata at L5 larval stage) and a coleopteran species (T. molitor at larval stage with 3-cm body length). Overnight cultured bacteria were injected into hemocoels of surface-sterilized larvae using microsyringes. Each treatment was replicated three times. Each replication used 10 larvae. Asterisks above standard error bars indicates significant differences between means of two strains for each dose at Type I error = 0.05 (LSD test).
Prediction of indole compounds produced by X. hominickii ANU101 (‘ANU’) and X. hominickii DY1 (‘DY’).
FIGURE 6Immunosuppressive and insecticidal activities of indole and its derivatives identified from X. hominickii culture broth. Acronyms of test compounds are described in Table 1. (A) Assessment of immunosuppressive activities using nodulation assay. Test compounds (1 μg/larva) were injected to L5 larvae of S. exigua along with E. coli (104 cfu/larva) using microsyringes. (B) Their inhibitory activities against hemocyte sPLA2 and cPLA2 of L5 larvae. Each treatment was replicated three times with independent samplings. Control (‘CON’) used DMSO solvent that was used for diluting test compounds. Each treatment was assessed using five larvae. Different letters above standard error bars indicate significant differences among means at Type I error = 0.05 (LSD test). (C) Their insecticidal activities against L3 larvae of S. exigua and P. xylostella using a leaf dipping method. Each treatment was replicated three times. Each replication used 10 larvae.
Prediction of secondary metabolites synthesized by NRPS-PKS of X. hominickii ANU101 (‘ANU’) and X. hominickii DY1 (‘DY’).
FIGURE 7Immunosuppressive and insecticidal activities of NRPS-PKS-derived secondary metabolites identified from X. hominickii culture broth. Acronyms of test compounds are described in Table 2. (A) Assessment of immunosuppressive activities using nodulation assay. Test compounds (1 μg/larva) were injected to L5 larvae of S. exigua along with E. coli (104 cfu/larva) using microsyringes. (B) Their inhibitory activities against hemocyte sPLA2 and cPLA2 of L5 larvae. Each treatment was replicated three times with independent samplings. Control (‘CON’) used DMSO solvent that was used for diluting test compounds. Each treatment was assessed using five larvae. Different letters above standard error bars indicate significant differences among means at Type I error = 0.05 (LSD test). (C) Their insecticidal activities against L3 larvae of S. exigua and P. xylostella using a leaf dipping method. Each treatment was replicated three times. Each replication used 10 larvae.
FIGURE 8Biosynthetic gene clusters associated with secondary metabolites of X. hominickii ANU1. (A) A genome map indicating NRPS-PKS and Lrp loci of X. hominickii ANU1. (B) Component analysis of each NRPS-PKS locus.
Variation in amino acid sequences of PKS and NRPS loci between ANU101 and DY1 strains of X. hominickii.
| Loci | AA | Variations | Rate (%) | |
| # | Locations | |||
| PKS1 | 2,065 | 11 | 168(M→I), 169(M→L), 219(D→N), 330(F→W), 410(A→G), 670(P→S), 871(T→A), 989(F→L), 1069(R→G), 1249(K→N), 1709(F→S) | 0.53 |
| PKS2 | 1,471 | 4 | 292(I→F), 491(D→G), 1012(Q→R), 1053(F→L) | 0.27 |
| PKS3 | 1,635 | 2 | 652(S→R), 1370(N→K) | 0.12 |
| PKS4 | 334 | 1 | 69(I→M) | 0.30 |
| NRPS1 | 947 | 5 | 130(D→N), 270(T→A), 351(T→A), 450(L→M), 510(F→M) | 0.53 |
| NRPS2 | 2,394 | 16 | 70(K→N), 190(F→G), 329(L→I), 391(C→S), 492(S→T), 550(D→E), 557(S→C), 630(Y→N), 829(F→W), 910(K→M), 1090(S→M), 1290(Q→K), 2069(R→S), 2211(G→D), 2290(K→N), 2397(E→S) | 0.67 |
| NRPS3 | 2,387 | 15 | 110(K→N), 170(Y→C), 312(F→Y), 371(N→S), 393(N→I), 431(Q→H), 669(E→G), 788(G→V), 1292(K→N), 1373(E→G), 1514(Q→L), 1670(L→W), 2172(P→Q), 2386(E→S), 2387(I→E) | 0.63 |
FIGURE 9Comparative analysis of NRPS-PKS gene expression between two strains of X. hominickii. (A) Their growth curves at 28°C in TSB broth. (B) Temporal expression levels of two Lrp genes during bacterial growth. Asterisks above standard error bars indicate significant differences between means of two strains at each time pint at Type I error = 0.05 (LSD test). (C) Comparative expression analysis of three NRPS (left panel) and four PKS (right panel) genes between the two strains during bacterial growth in TSB broth. (D) Comparative expression analysis of three NRPS (left panel) and four PKS (right panel) genes between two strains during bacterial growth in S. exigua. Each L5 larva was infected with 102 cfu of X. hominickii. Each treatment was independently replicated three times.